GAMRANI Halima

Prof. GAMRANI Halima

orcid

Research Focus & Metrics

Academic Career Length

47Years (1980-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2021 in BioMed Research International
Verified
Journal Article
Open access
PDF file
ARAsmaa Rhazouani
Asmaa Rhazouani
GHGAMRANI Halima
GAMRANI Halima
Mounir EL ACHABYMounir EL ACHABY
Mounir EL ACHABY
KAKhalid Aziz
Khalid Aziz
LGLhoucine Gebrati
Lhoucine Gebrati
Faissal AZIZFaissal AZIZ
Faissal AZIZ
Nanomaterials have been widely used in many fields in the last decades, including electronics, biomedicine, cosmetics, food processing, buildings, and aeronautics. The application of these nanomaterials in the medical field could improve diagnosis, treatment, and prevention techniques. Graphene oxide (GO), an oxidized derivative of graphene, is currently used in biotechnology and medicine for cancer treatment, drug delivery, and cellular imaging. Also, GO is characterized by various physicochemical properties, including nanoscale size, high surface area, and electrical charge. However, the toxic effect of GO on living cells and organs is a limiting factor that limits its use in the medical field. Recently, numerous studies have evaluated the biocompatibility and toxicity of GO in vivo and in vitro. In general, the severity of this nanomaterial’s toxic effects varies according to the administration route, the dose to be administered, the method of GO synthesis, and its physicochemical properties. This review brings together studies on the method of synthesis and structure of GO, characterization techniques, and physicochemical properties. Also, we rely on the toxicity of GO in cellular models and biological systems. Moreover, we mention the general mechanism of its toxicity.

1 January 1986 in Brain Research
Verified
Journal Article
Closed access
GHGAMRANI Halima
GAMRANI Halima
BOBrigitte Onteniente
Brigitte Onteniente
PSPhilippe Seguela
Philippe Seguela
MGMichel Geffard
Michel Geffard
ACAndre Calas
Andre Calas

1 April 1987 in Neuroscience
Verified
Journal Article
Closed access
MHM. Harandi
M. Harandi
MAM. Aguera
M. Aguera
GHGAMRANI Halima
GAMRANI Halima
MDM. Didier
M. Didier
MMMichel Maitre
Michel Maitre
MBM.F. Belin
M.F. Belin

1 September 2020 in Revue Neurologique
Verified
Journal Article
Closed access
ADA. Draoui
A. Draoui
OHO. El Hiba
O. El Hiba
AAA. Aimrane
A. Aimrane
AKA. El Khiat
A. El Khiat
GHGAMRANI Halima
GAMRANI Halima

1 June 2014 in Acta Histochemica
Verified
Journal Article
Closed access
HBHind Benammi
Hind Benammi
OHOmar El Hiba
Omar El Hiba
ARAbderrahmane Romane
Abderrahmane Romane
GHGAMRANI Halima
GAMRANI Halima

1 October 2011 in Acta Histochemica
Verified
Journal Article
Closed access
WSWafa Sansar
Wafa Sansar
SASamir Ahboucha
Samir Ahboucha
GHGAMRANI Halima
GAMRANI Halima